Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adaptive Phage, Amgen, Circ, Demerx, Idorsia, Kiromic, Lannett, Linnaeus, RDIF, Tarus, Vertex.
Mouse traps. Bird excrement. Insects. Rusted equipment and peeling paint. Employees not gowning properly for a clean room or washing their hands after using the bathroom. Those are just some of the things the FDA is missing as it relies on document reviews, sampling at the border and other alternatives to onsite drug inspections during the pandemic.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acadia, Affibody, Alphamab, Altrubio, Amylyx, Cyclo, Huya, Inmagene, Melior, Oncopeptides, Rocket.
The Institute for Clinical and Economic Review (ICER) took Fibrogen Inc., of San Francisco, to task for not disclosing data from completed roxadustat trials.
LONDON – The National Health Service (NHS) in the U.K. has agreed to reimburse Zolgensma, the one-off gene therapy treatment for spinal muscular atrophy billed as the most expensive drug in the world, after a confidential deal was struck with Novartis Gene Therapies.
The voluminous American Rescue Plan – the second largest stimulus package in U.S. history – has something for everyone. Almost. The $1.9 trillion package that passed the Senate over the weekend and is expected to be passed by the House March 9 failed to extend the current moratorium, set to expire April 1, on the 2% Medicare sequestration.
More than a decade after first approving Actemra (tocilizumab) for the treatment of rheumatoid arthritis, the FDA has added a sixth use to its label: slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease.
RSS
